APOBEC4 Enhances the Replication of HIV-1

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Marino, Daniela ^a,b   Perković, Mario ^a,b,d   Hain, Anika ^a   Vasudevan, Ananda A Jaguva ^a   Hofmann, Henning ^a,b,e   Hanschmann, Kay Martin ^b   Mühlebach, Michael D ^b   Schumann, Gerald G ^b   König, Renate ^b,c   Cichutek, Klaus ^b   Häussinger, Dieter ^a   Münk, Carsten ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c BURNHAM INSTITUTE   (United States)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 4; CYTIDINE DEAMINASE; MESSENGER RNA; SINGLE STRANDED DNA; UNCLASSIFIED DRUG; APOBEC4 PROTEIN, HUMAN; CYTIDINE;

293T CELL LINE; A3.01 CELL LINE; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOPLASM; DEAMINATION; DOSE RESPONSE; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IN VITRO STUDY; INFECTION SENSITIVITY; JURKAT CELL LINE; MALE; NONHUMAN; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TESTIS; VIRUS REPLICATION; WILD TYPE; LONG TERMINAL REPEAT; METABOLISM; PHYSIOLOGY; PROMOTER REGION;

CELL LINE; CYTIDINE; CYTIDINE DEAMINASE; DEAMINATION; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MALE; PROMOTER REGIONS, GENETIC; TESTIS; VIRUS REPLICATION;

EID: 84973911535     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155422     Document Type: Article

References (92)

1. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 2002; 79(3):285-96. PMID: 11863358
2. Navaratnam N, Sarwar R. An overview of cytidine deaminases. International journal of hematology. 2006; 83(3):195-200. doi: 10.1532/IJH97.06032 PMID: 16720547.
3. Rogozin IB, Basu MK, Jordan IK, Pavlov YI, Koonin EV. APOBEC4, a new member of the AID/APO-BEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle. 2005; 4(9):1281-5. PMID: 16082223.
4. Prohaska KM, Bennett RP, Salter JD, Smith HC. The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions. Wiley interdisciplinary reviews RNA. 2014; 5(4):493-508. doi: 10.1002/ wrna.1226 PMID: 24664896; PubMed Central PMCID: PMC4062598.
5. Münk C, Willemsen A, Bravo IG. An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals. BMC evolutionary biology. 2012; 12:71. doi: 10.1186/1471-2148-12-71 PMID: 22640020; PubMed Central PMCID: PMC3495650.
6. Vartanian JP, Guetard D, Henry M, Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science. 2008; 320(5873):230-3. doi: 10.1126/ science.1153201 PMID: 18403710
7. Vartanian JP, Henry M, Marchio A, Suspene R, Aynaud MM, Guetard D, et al. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLOS Pathog. 2010; 6(5):e1000928. doi: 10.1371/journal.ppat. 1000928 PMID: 20523896
8. Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. AnnuRevImmunol. 2008; 26:317-53.
9. Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, et al. APOBEC3A is a potent inhibitor of adenoassociated virus and retrotransposons. CurrBiol. 2006; 16(5):480-5.
10. Tsuge M, Noguchi C, Akiyama R, Matsushita M, Kunihiro K, Tanaka S, et al. G to A hypermutation of TT virus. Virus research. 2010; 149(2):211-6. doi: 10.1016/j.virusres.2010.01.019 PMID: 20138932.
11. Peng ZG, Zhao ZY, Li YP, Wang YP, Hao LH, Fan B, et al. Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus. Hepatology. 2011; 53(4):1080-9. doi: 10.1002/hep.24160 PMID: 21480314.
12. Suspene R, Aynaud MM, Koch S, Pasdeloup D, Labetoulle M, Gaertner B, et al. Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo. JVirol. 2011; 85(15):7594-602. [pii]; doi: 10.1128/JVI.00290-11
13. Fehrholz M, Kendl S, Prifert C, Weissbrich B, Lemon K, Rennick L, et al. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses. The Journal of general virology. 2012; 93(Pt 3):565-76. doi: 10.1099/vir.0.038919-0 PMID: 22170635.
14. Muckenfuss H, Hamdorf M, Held U, Perkovic M, Löwer J, Cichutek K, et al. APOBEC3 proteins inhibit human LINE-1 retrotransposition. JBiolChem. 2006; 281(31):22161-72.
15. Schumann GG, Gogvadze EV, Osanai-Futahashi M, Kuroki A, Münk C, Fujiwara H, et al. Unique functions of repetitive transcriptomes. IntRevCell MolBiol. 2010; 285:115-88.
16. Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science. 2014; 343(6176):1221-8. doi: 10.1126/science. 1243462 PMID: 24557838.
17. Mariani R, Chen D, Schröfelbauer B, Navarro F, König R, Bollman B, et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 2003; 114(1):21-31. PMID: 12859895
18. Münk C, Jensen BE, Zielonka J, Häussinger D, Kamp C. Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein. Viruses. 2012; 4 (11):3132-61. [pii]; doi: 10.3390/v4113132 PMID: 23202519
19. Löchelt M, Romen F, Bastone P, Muckenfuss H, Kirchner N, Kim YB, et al. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. ProcNatlAcadSciUSA. 2005; 102 (22):7982-7.
20. Perkovic M, Schmidt S, Marino D, Russell RA, Stauch B, Hofmann H, et al. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. JBiolChem. 2009; 284(9):5819-26.
21. Beggel B, Münk C, Daumer M, Hauck K, Häussinger D, Lengauer T, et al. Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B. Journal of viral hepatitis. 2013; 20(12):882-9. doi: 10.1111/jvh.12110 PMID: 24304458.
22. Vasudevan AA, Smits SH, Hoppner A, Häussinger D, Koenig BW, Münk C. Structural features of antiviral DNA cytidine deaminases. Biological chemistry. 2013; 394(11):1357-70. doi: 10.1515/hsz-2013-0165 PMID: 23787464.
23. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002; 418(6898):646-50. PMID: 12167863
24. Russell RA, Wiegand HL, Moore MD, Schafer A, McClure MO, Cullen BR. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. JVirol. 2005; 79(14):8724-31.
25. Derse D, Hill SA, Princler G, Lloyd P, Heidecker G. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. ProcNatlAcadSciUSA. 2007; 104 (8):2915-20.
26. Stavrou S, Nitta T, Kotla S, Ha D, Nagashima K, Rein AR, et al. Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex. ProcNatlAcadSciUSA. 2013. [pii]; doi: 10.1073/pnas.1217399110
27. Kolokithas A, Rosenke K, Malik F, Hendrick D, Swanson L, Santiago ML, et al. The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3. Journal of virology. 2010; 84(20):10933-6. doi: 10.1128/JVI.01023-10 PMID: 20702647; PubMed Central PMCID: PMC2950561.
28. Stavrou S, Blouch K, Kotla S, Bass A, Ross SR. Nucleic Acid recognition orchestrates the anti-viral response to retroviruses. Cell host & microbe. 2015; 17(4):478-88. doi: 10.1016/j.chom.2015.02.021 PMID: 25816774; PubMed Central PMCID: PMC4393365.
29. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. The Journal of biological chemistry. 1999; 274(26):18470-6. PMID: 10373455.
30. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000; 102(5):553-63. PMID: 11007474.
31. Arakawa H, Hauschild J, Buerstedde JM. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science. 2002; 295(5558):1301-6. doi: 10.1126/science. 1067308 PMID: 11847344.
32. Petersen-Mahrt SK, Harris RS, Neuberger MS. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 2002; 418(6893):99-103. doi: 10.1038/nature00862 PMID: 12097915.
33. Harris RS, Sale JE, Petersen-Mahrt SK, Neuberger MS. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Current biology: CB. 2002; 12(5):435-8. PMID: 11882297.
34. Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature. 2002; 416(6878):340-5. doi: 10.1038/nature727 PMID: 11875397.
35. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000; 102(5):565-75. PMID: 11007475.
36. MacDuff DA, Demorest ZL, Harris RS. AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res. 2009; 37(6):1854-67. doi: 10.1093/nar/gkp030 PMID: 19188259
37. Metzner M, Jack HM, Wabl M. LINE-1 retroelements complexed and inhibited by activation induced cytidine deaminase. PLOS one. 2012; 7(11):e49358. doi: 10.1371/journal.pone.0049358 PMID: 23133680; PubMed Central PMCID: PMC3487726.
38. Yu Q, Chen D, Konig R, Mariani R, Unutmaz D, Landau NR. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J Biol Chem. 2004; 279(51):53379-86. [pii]; doi: 10.1074/jbc.M408802200 PMID: 15466872
39. Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. CurrBiol. 2004; 14(15):1392-6.
40. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. Journal of virology. 2004; 78 (11):6073-6. doi: 10.1128/JVI.78.11.6073-6076.2004 PMID: 15141007; PubMed Central PMCID: PMC415831.
41. Teng B, Burant CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 1993; 260(5115):1816-9. PMID: 8511591.
42. Navaratnam N, Morrison JR, Bhattacharya S, Patel D, Funahashi T, Giannoni F, et al. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. The Journal of biological chemistry. 1993; 268(28):20709-12. PMID: 8407891.
43. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell. 1987; 50(6):831-40. PMID: 3621347.
44. Mehta A, Kinter MT, Sherman NE, Driscoll DM. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Molecular and cellular biology. 2000; 20(5):1846-54. PMID: 10669759; PubMed Central PMCID: PMC85365.
45. Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs. Nature structural & molecular biology. 2011; 18(2):230-6. doi: 10.1038/nsmb.1975 PMID: 21258325; PubMed Central PMCID: PMC3075553.
46. Petit V, Guetard D, Renard M, Keriel A, Sitbon M, Wain-Hobson S, et al. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. Journal of molecular biology. 2009; 385 (1):65-78. doi: 10.1016/j.jmb.2008.10.043 PMID: 18983852.
47. Bishop KN, Holmes RK, Sheehy AM, Malim MH. APOBEC-mediated editing of viral RNA. Science. 2004; 305(5684):645. doi: 10.1126/science.1100658 PMID: 15286366.
48. Ikeda T, Ohsugi T, Kimura T, Matsushita S, Maeda Y, Harada S, et al. The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Res. 2008; 36(21):6859-71. [pii]; doi: 10.1093/nar/gkn802 PMID: 18971252
49. Ikeda T, Ong EB, Watanabe N, Sakaguchi N, Maeda K, Koito A. Creation of chimeric human/rabbit APOBEC1 with HIV-1 restriction and DNA mutation activities. Scientific reports. 2016; 6:19035. doi: 10. 1038/srep19035 PMID: 26738439; PubMed Central PMCID: PMCPMC4704027.
50. Ikeda T, Abd El Galil KH, Tokunaga K, Maeda K, Sata T, Sakaguchi N, et al. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons. Nucleic acids research. 2011; 39(13):5538-54. doi: 10.1093/nar/gkr124 PMID: 21398638; PubMed Central PMCID: PMC3141244.
51. Sato Y, Probst HC, Tatsumi R, Ikeuchi Y, Neuberger MS, Rada C. Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy. The Journal of biological chemistry. 2010; 285(10):7111-8. doi: 10.1074/jbc.M109.052977 PMID: 20022958; PubMed Central PMCID: PMC2844160.
52. Lada AG, Krick CF, Kozmin SG, Mayorov VI, Karpova TS, Rogozin IB, et al. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast. Biochemistry Biokhimiia. 2011; 76(1):131-46. PMID: 21568845; PubMed Central PMCID: PMC3906858.
53. Harris RS, Petersen-Mahrt SK, Neuberger MS. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. MolCell. 2002; 10(5):1247-53. S1097276502007426 [pii].
54. Esnault C, Millet J, Schwartz O, Heidmann T. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res. 2006; 34(5):1522-31. PMID: 16537839
55. Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PT, Yu XF. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. JVirol. 2007; 81(17):9577-83.
56. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. JVirol. 1986; 59(2):284-91.
57. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995; 206(2):935-44. doi: 10.1006/viro. 1995.1016 PMID: 7531918.
58. Mariani R, Rasala BA, Rutter G, Wiegers K, Brandt SM, Krausslich HG, et al. Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly. JVirol. 2001; 75(7):3141-51.
59. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrobial agents and chemotherapy. 2002; 46(6):1896-905. PMID: 12019106; PubMed Central PMCID: PMC127242.
60. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996; 381(6584):661-6. doi: 10.1038/381661a0 PMID: 8649511
61. Nowarski R, Britan-Rosich E, Shiloach T, Kotler M. Hypermutation by intersegmental transfer of APO-BEC3G cytidine deaminase. NatStructMolBiol. 2008; 15(10):1059-66. [pii]; doi: 10.1038/nsmb.1495
62. Jaguva Vasudevan AA, Perkovic M, Bulliard Y, Cichutek K, Trono D, Häussinger D, et al. Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G. Journal of virology. 2013; 87(16):9030-40. doi: 10.1128/JVI.03385-12 PMID: 23760237; PubMed Central PMCID: PMC3754047.
63. Polevoda B, McDougall WM, Tun BN, Cheung M, Salter JD, Friedman AE, et al. RNA binding to APO-BEC3G induces the disassembly of functional deaminase complexes by displacing single-stranded DNA substrates. Nucleic acids research. 2015; 43(19):9434-45. doi: 10.1093/nar/gkv970 PMID: 26424853; PubMed Central PMCID: PMCPMC4627094.
64. Iwatani Y, Takeuchi H, Strebel K, Levin JG. Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. J Virol. 2006; 80(12):5992-6002. [pii]; doi: 10. 1128/JVI.02680-05 PMID: 16731938
65. McDougall WM, Okany C, Smith HC. Deaminase activity on single-stranded DNA (ssDNA) occurs in vitro when APOBEC3G cytidine deaminase forms homotetramers and higher-order complexes. The Journal of biological chemistry. 2011; 286(35):30655-61. doi: 10.1074/jbc.M111.269506 PMID: 21737457; PubMed Central PMCID: PMCPMC3162426.
66. Wagner E, Cotten M, Foisner R, Birnstiel ML. Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proceedings of the National Academy of Sciences of the United States of America. 1991; 88(10):4255-9. PMID: 2034670; PubMed Central PMCID: PMCPMC51637.
67. Jang H, Abraham SJ, Chavan TS, Hitchinson B, Khavrutskii L, Tarasova NI, et al. Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region. The Journal of biological chemistry. 2015; 290(15):9465-77. doi: 10.1074/jbc.M114.620724 PMID: 25713064; PubMed Central PMCID: PMCPMC4392252.
68. Wu LJ, Xu LR, Liao JM, Chen J, Liang Y. Both the C-terminal polylysine region and the farnesylation of K-RasB are important for its specific interaction with calmodulin. PLOS one. 2011; 6(7):e21929. doi: 10. 1371/journal.pone.0021929 PMID: 21750741; PubMed Central PMCID: PMCPMC3130059.
69. Paranjpe S, Craigo J, Patterson B, Ding M, Barroso P, Harrison L, et al. Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Res Hum Retroviruses. 2002; 18(17):1271-80. doi: 10.1089/088922202320886316 PMID: 12487815.
70. Le Tortorec A, Le Grand R, Denis H, Satie AP, Mannioui K, Roques P, et al. Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLOS one. 2008; 3(3):e1792. doi: 10.1371/journal.pone.0001792 PMID: 18347738; PubMed Central PMCID: PMC2268241.
71. Lowe SH, Sankatsing SU, Repping S, van der Veen F, Reiss P, Lange JM, et al. Is the male genital tract really a sanctuary site for HIV? Arguments that it is not. AIDS. 2004; 18(10):1353-62. PMID: 15199311.
72. Roulet V, Satie AP, Ruffault A, Le Tortorec A, Denis H, Guist'hau O, et al. Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. The American journal of pathology. 2006; 169(6):2094-103. PMID: 17148672; PubMed Central PMCID: PMCPMC1762481.
73. Fieni F, Stone M, Ma ZM, Dutra J, Fritts L, Miller CJ. Viral RNA levels and env variants in semen and tissues of mature male rhesus macaques infected with SIV by penile inoculation. PLOS one. 2013; 8(10): e76367. doi: 10.1371/journal.pone.0076367 PMID: 24146859; PubMed Central PMCID: PMCPMC3795772.
74. Houzet L, Matusali G, Dejucq-Rainsford N. Origins of HIV-infected leukocytes and virions in semen. J Infect Dis. 2014; 210 Suppl 3:S622-30. doi: 10.1093/infdis/jiu328 PMID: 25414416.
75. Bednar MM, Hauser BM, Ping LH, Dukhovlinova E, Zhou S, Arrildt KT, et al. R5 Macrophage-Tropic HIV-1 in the Male Genital Tract. Journal of virology. 2015; 89(20):10688-92. doi: 10.1128/JVI.01842-15 PMID: 26223642; PubMed Central PMCID: PMCPMC4580182.
76. Matusali G, Dereuddre-Bosquet N, Le Tortorec A, Moreau M, Satie AP, Mahe D, et al. Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy. Journal of virology. 2015; 89(11):5772-87. doi: 10.1128/JVI.03628-14 PMID: 25833047; PubMed Central PMCID: PMCPMC4442442.
77. Muciaccia B, Uccini S, Filippini A, Ziparo E, Paraire F, Baroni CD, et al. Presence and cellular distribution of HIV in the testes of seropositive subjects: an evaluation by in situ PCR hybridization. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1998; 12 (2):151-63. PMID: 9472980.
78. Nuovo GJ, Becker J, Simsir A, Margiotta M, Khalife G, Shevchuk M. HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization. The American journal of pathology. 1994; 144(6):1142-8. PMID: 8203455; PubMed Central PMCID: PMC1887452.
79. Muciaccia B, Filippini A, Ziparo E, Colelli F, Baroni CD, Stefanini M. Testicular germ cells of HIV-seropositive asymptomatic men are infected by the virus. J Reprod Immunol. 1998; 41(1-2):81-93. PMID: 10213302.
80. Shevchuk MM, Nuovo GJ, Khalife G. HIV in testis: quantitative histology and HIV localization in germ cells. J Reprod Immunol. 1998; 41(1-2):69-79. PMID: 10213301.
81. Shehu-Xhilaga M, Kent S, Batten J, Ellis S, Van der Meulen J, O'Bryan M, et al. The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the post-acute stage of infection. Retrovirology. 2007; 4:7. doi: 10.1186/1742-4690-4-7 PMID: 17266752; PubMed Central PMCID: PMC1805449.
82. Santangelo PJ, Rogers KA, Zurla C, Blanchard EL, Gumber S, Strait K, et al. Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nature methods. 2015. doi: 10.1038/nmeth.3320 PMID: 25751144.
83. Crowell RC, Kiessling AA. Endogenous retrovirus expression in testis and epididymis. Biochem Soc Trans. 2007; 35(Pt 3):629-33. doi: 10.1042/BST0350629 PMID: 17511667.
84. Steinhoff C, Schulz WA. Transcriptional regulation of the human LINE-1 retrotransposon L1.2B. Mol Genet Genomics. 2003; 270(5):394-402. doi: 10.1007/s00438-003-0931-2 PMID: 14530963.
85. Cronauer MV, Schulz WA, Burchardt T, Ackermann R, Burchardt M. Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines. Oncogene. 2004; 23 (20):3541-9. doi: 10.1038/sj.onc.1207346 PMID: 15077179.
86. Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. NatMed. 2003; 9(11):1398-403.
87. Wiegand HL, Doehle BP, Bogerd HP, Cullen BR. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 2004; 23(12):2451-8. PMID: 15152192
88. Hoffmeyer A, Grosse-Wilde A, Flory E, Neufeld B, Kunz M, Rapp UR, et al. Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor alpha gene expression in T lymphocytes. The Journal of biological chemistry. 1999; 274(7):4319-27. PMID: 9933633.
89. Folks T, Benn S, Rabson A, Theodore T, Hoggan MD, Martin M, et al. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proceedings of the National Academy of Sciences of the United States of America. 1985; 82(13):4539-43. PMID: 2989831; PubMed Central PMCID: PMC391138.
90. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, et al. A transient threeplasmid expression system for the production of high titer retroviral vectors. Nucleic acids research. 1995; 23(4):628-33. PMID: 7899083; PubMed Central PMCID: PMC306730.
91. Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol. 1995; 69(7):4582-6. PMID: 7769728
92. Simon JH, Southerling TE, Peterson JC, Meyer BE, Malim MH. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. Journal of virology. 1995; 69(7):4166-72. PMID: 7769676; PubMed Central PMCID: PMC189153.